Cellectis (CLLS) Invested Capital (2014 - 2026)

Cellectis' Invested Capital history runs 12 years deep, the most recent figure standing at $8.9 million for Q1 2026.

• In Q1 2026, Invested Capital fell 46.96% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at $229.4 million (up 38.45% YoY), while the FY2025 annual figure was $114.1 million, down 17.57% from the prior year.
• Invested Capital for Q1 2026 stood at $8.9 million, down from $114.1 million in the prior quarter.
• The five-year high for Invested Capital was $138.4 million in Q4 2024, with the low at $5.1 million in Q3 2023.
• The 5-year median for Invested Capital is $11.3 million (2022), against an average of $38.8 million.
• The sharpest annual moves came in 2023 and 2025: Invested Capital sank 58.85% in 2023, then jumped 1621.43% in 2025.
• Cellectis' Invested Capital stood at $117.5 million in 2022, then fell by 21.63% to $92.1 million in 2023, then soared by 50.32% to $138.4 million in 2024, then retreated by 17.57% to $114.1 million in 2025, then plunged by 92.2% to $8.9 million in 2026.
• Business Quant data shows CLLS's Invested Capital at $8.9 million in Q1 2026, $114.1 million in Q4 2025, and $18.2 million in Q3 2025.